ImmunoScape presented new preclinical data at the AACR Annual Meeting 2026, highlighting the potential of its Seed and Boost™ platform in solid tumor immunotherapy. Key...
Mar 4, 2026
ImmunoScape Announces Memorandum of Understanding for Clinical Trial with Premier U.S. Cancer Center
The company also announced a strategic investment from Leonardo DiCaprio SINGAPORE and SAN DIEGO-- ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures...
Nov 13, 2025
“Seed-and-Boost” Approach with Breakthrough Potential, Poised to Transform the Cancer Immunotherapy Landscape SINGAPORE -- ImmunoScape Pte. Ltd., an A*STAR spin out...
Nov 4, 2025
Exclusive collaboration and license agreement focuses on advancing novel, T cell therapy “Seed-and-Boost” approach exploiting the mechanism of the CUE-100 series of...